Sana Biotechnology, Inc. SANA
2.43 USD -0.03 (-1.42%)
At closeNov 11, 2026, 6:02 AM EST
2.40 -0.03 -1.23%
Pre-market · Nov 11, 6:02 AM ET
2.32 Day range 2.52
2.22 52-week range 5.49
- YTD
- -40.29%
- 1 year
- -42.69%
Analyst view
Price target (mean) 8.43 +246.9% upside
Now 2.43
- Target (low)
- 6.00
- Target (mean)
- 8.43
- Target (high)
- 12.00
Ratings (0m) 9 8 buy · 1 hold · 0 sell
- Strong buy2
- Buy6
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 9
- 1 month ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.13351 | -0.19 – -0.10 | -0.15 | +11.0% | 0 | 0.0% | 4 |
| Next quarter | -0.16266 | -0.20 – -0.11064 | -0.16 | -1.7% | 0 | 0.0% | 4 |
| Current year | -0.59111 | -0.71 – -0.48 | -0.67 | +11.8% | 0 | 0.0% | 4 |
| Next year | -0.55511 | -0.74 – -0.42 | -0.59111 | +6.1% | 0 | 0.0% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 14, 2026 | B of A Securities | Maintained | Buy | Buy |
| Apr 14, 2026 | Wedbush | Maintained | Outperform | Outperform |
| Mar 4, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 6, 2026 | B of A Securities | Maintained | Buy | Buy |
| Nov 7, 2025 | Wedbush | Maintained | Outperform | Outperform |
| Nov 7, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 30, 2025 | Citizens | Maintained | Market Outperform | Market Outperform |
| Sep 24, 2025 | Wedbush | Initiated | — | Outperform |
| Jun 24, 2025 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Apr 24, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 18, 2025 | Citizens Capital Markets | Upgrade | Market Perform | Market Outperform |
| Mar 18, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 14, 2025 | Jefferies | Initiated | — | Buy |
| Jan 8, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jan 8, 2025 | TD Cowen | Upgrade | Hold | Buy |
| Nov 27, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 11, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 5, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 5, 2024 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Aug 9, 2024 | Citigroup | Maintained | Buy | Buy |
| Aug 9, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 9, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 1, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Mar 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jan 16, 2024 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Oct 12, 2023 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Sep 25, 2023 | JMP Securities | Initiated | — | Market Outperform |
| Sep 5, 2023 | Citigroup | Initiated | — | Buy |
| Aug 14, 2023 | TD Cowen | Initiated | — | Market Perform |
| May 2, 2023 | HC Wainwright & Co. | Initiated | — | Neutral |